At ADAMAS, our mission is to provide our clients with best-in-class expertise; our team consists of the top industry knowledge of clinical quality assurance. But we go even further beyond that, to ensure that we remain true partners to our clients, working with your...
For over two decades ADAMAS has shown an unwavering commitment to being a market leader that sets the standard for best in class service. Part of being an innovator is to be continuously looking at how we can improve. We must always be evaluating not only our services...
Learn how ADAMAS ensures industry-leading data privacy and cybersecurity compliance through robust policies, secure platforms, and expert oversight—protecting clients against evolving risks.
ADAMAS Consulting is delighted to announce the opening of our new office located in San Diego, California. ADAMAS brings 23 years of thought leadership in Quality Assurance to the American West. The challenging year the industry has collectively faced has driven the...
Understand how implementing KRIs and QTLs is essential to meeting ICH E6(R2) requirements and preparing for the risk-based focus of the upcoming ICH E6(R3) revision.
Discover how ADAMAS delivers enterprise-grade QA compliance with advanced data security, privacy protocols, and a robust Quality Management System that exceeds industry standards.
Could a second, potentially more contagious wave, of COVID-19 bring further disruption to travel and clinical trial activities? Is it possible to meet the current oversight and compliance expectations of regulatory authorities? We are all aware of the initial impact...
It’s a tough choice – new drugs for patients or the health and safety of your valued staff? With ADAMAS Consulting, you do not have to choose. As we keep hearing these are unprecedented times, and just recently there have been concerning articles in the scientific...
The U.S. Food and Drug Administration has announced the retirement of the MedWatch to Manufacturer Program (MMP) as of 31st July 2020. The program provided participating drug and biologic manufacturers with a means of receiving information from the FDA on serious...
“The only constant in life is change”-Heraclitus. This cannot be truer in today’s context. In the past two decades, clinical research industry, has gone through a paradigm shift from the use of paper-based systems to web based electronic systems and from traditional...
Ergomed Group announces the appointment of Jovan Willford as CEO. Start date November 2nd.
RQA 8th Global QA Conference 2026 | London, UK
From Reactive Compliance to Strategic Partnership: How Clinical Quality Is Evolving
FDA’s Real-Time Clinical Trial Initiative: Endorses Data-Enabled QA Oversight
SCOPE Europe 2026 | Barcelona, Spain